Are You Eligible to File a Claim for Injuries Related to Camp Lejeune?
Important Case Information At this time, our firm is only handling cases in which there has been a pancreatic cancer diagnosis within the last two months.
What You Need To Know About Incretin-Based Diabetes Drugs
Diabetes drugs such as Victoza, Janumet, Januvia, Byetta and Onglyza may increase the risk for developing pancreatic cancer.
Type 2 diabetes is a chronic condition affecting approximately 27 million people in the United States. While there are several types of treatment for type 2 diabetes, incretin-based diabetes drugs are 9 billion dollar business and are prescribed to thousands of people each year. They work to stimulate insulin secretion in the body and are used along with diet and exercise to regulates blood sugar in the body. While these generally are effective drugs for its intended purpose, there is a rising concern about an increased risk for pancreatic cancer among those who take incretin-based drugs.
Several studies suggest incretin-based therapies, including Januvia, Byetta, Victoza and Janumet are associated with an increased risk for pancreatic cancer, a very serious form of cancer. Further, recent research supporting this find has been been conducted. Rather than include a warning label on the drugs, manufacturers have failed to warn consumers of the danger of developing pancreatic cancer. If you or a loved one has suffered from pancreatic cancer after taking an incretin-based drug therapy, contact the aggressive lawyers at The Ruth Law Team who are here to fight against deceptive drugmakers on your behalf. Call us at (888) 783-8378 to speak to someone right now.
Contact Us
See What Our Clients Are Saying
What Happens Next?
At The Ruth Law Team, we understand that this may be your first time seeking legal counsel and how intimidating that decision might be. This is why we have simplified the process to help you make the right decision for your circumstances. This 3-step process includes:
Complete Our Case Evaluation Form
This quick survey will help us better understand what happened and which attorney is the best fit for your situation.
Speak with One of Our Attorneys
The best way for you to have a clear idea your options is to speak with an attorney who specializes in your area of need.
Submit Your
Claim
Once you decide that The Ruth Law Team is the right option to represent you, we will begin the process of submitting your claim.
Pancreatic Cancer Detection and Symptions
As the name suggests, pancreatic cancer forms within the pancreas and generally spreads very quickly. Unfortunately, it is difficult to detect in its early stages. If you’ve taken incretin-based therapies such as Bayetta, Januvia, or Janumet for your type 2 diabetes, you may be at a higher risk for pancreatitis and/or pancreatic cancer.
Symptoms of pancreatic cancer include the following:
- Loss of appetite and weight loss
- Upper-abdominal pain that may radiate throughout the back
- Blood clots
- Fatigue
- Jaundice, or yellowing of the skin and eyes
Pancreatic cancer occurs when cells within the pancreas develop mutations in the DNA. Taking incretion drugs such as Januvia, Janumet, Onglyza, Byetta, Bydureon and Victoza for Type-2 diabetes or Saxenda for weight loss could greatly increase your risk for pancreatic cancer. We don’t want to see anyone needlessly suffer from this terrible form of cancer, especially at the hands of deceptive and negligent drug manufacturers.
Legal Update The initial MDL, or multidistrict litigation, formed against drug manufacturers Merck, Amylin, Eli Lilly and Novo Nordisk formed was initially dismissed by a federal trial judge in November of 2015. However, this opinion was reversed on 12/6/18 on appeal to the 9th Federal Circuit. A mandate was issued on 1/2/18, and a preliminary hearing has now been set for February 27, 2018.
Lawsuits filed within MDL 2452 claim the manufacturers of these drugs “willfully, wantonly and with malice withheld the knowledge of an increased risk of pancreatic cancer in users of the Drugs to prevent any chances of their products’ registration being delayed or rejected by [the] FDA.” This failure to warn may have cost the lives of thousands of innocent people.
Lawsuits filed within MDL 2452 claim the manufacturers of these drugs “willfully, wantonly and with malice withheld the knowledge of an increased risk of pancreatic cancer in users of the Drugs to prevent any chances of their products’ registration being delayed or rejected by [the] FDA.” This failure to warn may have cost the lives of thousands of innocent people.
Contact Our Attorneys
If you are looking for a lawyer to handle your Januvia or Byetta case, contact the attorneys at The Ruth Law Team. The Type II diabetes drugs Victoza, Onglyza, Janumet and the weight-loss drug Saxenda are also of concern to us, as they are similar medications that may be linked to a higher risk of pancreatic cancer.
Incretin therapies aren’t the only type of diabetes drugs we’ve been investigating. Ivokana is a diabetes drug that may be linked to ketoacidosis and an increased risk of foot and leg amputations in patients with type 2 diabetes. It’s time we all work to stop big pharma companies from failing to put patients’ health before profits! For more than 40 years our firm has represented victims of personal injury from negligent parties such as drug manufacturers. We have the ability to accept these pancreatic cancer cases nationwide, so don’t hesitate to call our product liability attorneys (888) 783-8378 today.
About The Ruth Law Team
For over 40 years, The Ruth Law Team has been helping those who were injured due to an accident, defective product, nursing home abuse, and more. If you or someone you love was wrongfully hurt, The Ruth Law Team will guide and support you through the legal process.
Our team of passionate and experienced personal injury attorneys will fight for what you deserve. If you would like to speak with one of our attorneys and have your case evaluated, please don’t hesitate to give us a call at (888) 783-8378. Our lines are open 24/7.
Our Attorneys:
